Chiba et al 1997
Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997;112(6):1798-810.
DeMeester et al 1999
DeMeester TR, Peters JH, Bremner CG, Chandrasoma P. Biology of gastroesophageal reflux disease:
pathophysiology relating to medical and surgical treatment. Annu Rev Med 1999;50:469-506.
Euler and Ament 1977
Euler AR, Ament ME. Value of esophageal manometric studies in the gastroesophageal reflux of infancy.
Pediatrics 1977;59(1):58-61.
Gilger et al 2008
Gilger MA, El-Serag HB, Gold BD, Dietrich CL, Tsou V, McDuffie A, et al. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr 2008;47(2):141-6.
Gold 2004a
Gold BD. Gastroesophageal reflux disease: could intervention in childhood reduce the risk of later complications? Am J Med 2004;117 Suppl 5A:23S-29S.
Gold 2004b
Gold BD. Review article: epidemiology and management of gastro-oesophageal reflux in children. Aliment Pharmacol Ther 2004;19 Suppl 1:22-7.
Gold et al 2007
Gold BD, Gunasekaran T, Tolia V, Wetzler G, Conter H, Traxler B, et al. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007;45(5):520-9.
Gunasekaran and Hassall 1993
Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993;123(1):148-54.
Gunasekaran et al 2002
Gunasekaran T, Gupta S, Gremse D, Karol M, Pan WJ, Chiu YL, et al. Lansoprazole in adolescents with gastroesophageal reflux disease: pharmacokinetics, pharmacodynamics, symptom relief efficacy, and tolerability. J Pediatr Gastroenterol Nutr 2002;35 Suppl 4:S327-35.
Gunasekaran et al 2008
Gunasekaran TS, Dahlberg M, Ramesh P, Namachivayam G. Prevalence and associated features of gastroesophageal reflux symptoms in a Caucasian-predominant adolescent school population. Dig Dis Sci 2008;53(9):2373-9.
Gupta et al 2006
Gupta SK, Hassall E, Chiu YL, Amer F, Heyman MB. Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci 2006;51(5):858-63.
Gustafsson and Tibbling 1988
Gustafsson PM, Tibbling L. 24-hour oesophageal two-level pH monitoring in healthy children and adolescents. Scand J Gastroenterol 1988;23(1):91-4.
Hassall 1997
Hassall E. Co-morbidities in childhood Barrett’s esophagus. J Pediatr Gastroenterol Nutr 1997;25(3):255-60.
Hassall et al 2000
Hassall E, Israel D, Shepherd R, Radke M, Dalväg A, Sköld B, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000;137(6):800-7.
Hassall et al 2007
Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007;150(3):262-7.
Kato et al 2004
Kato S, Nishino Y, Ozawa K, Konno M, Maisawa S, Toyoda S, et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol 2004;39(8):734-8.
Kawahara et al 1997
Kawahara H, Dent J, Davidson G. Mechanisms responsible for gastroesophageal reflux in children.
Gastroenterology 1997;113(2):399-408.
Kawahara et al 2002
Kawahara H, Nakajima K, Yagi M, Okuyama H, Kubota A, Okada A. Mechanisms responsible for recurrent gastroesophageal reflux in neurologically impaired children who underwent laparoscopic Nissen fundoplication. Surg Endosc 2002;16(5):767-71.
Kinoshita et al 2006
Kinoshita Y, Kobayashi T, Kato M, Asahina K, Haruma K, Shimatani T, et al. The pharmacodynamic effect of omeprazole 10 mg and 20 mg once daily in patients with nonerosive reflux disease in Japan. J Gastroenterol 2006;41(6):554-61.
Mössner et al 1995
Mössner J, Hölscher AH, Herz R, Schneider A. A double-blind study of pantoprazole and omeprazole in the treatment of reflux esophagitis: a multicentre trial. Aliment Pharmacol Ther 1995;9(3):321-6.
Nelson et al 2000
Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of gastroesophageal reflux during childhood: a pediatric practice-based survey. Pediatric Practice Research Group. Arch Pediatr Adolesc Med 2000;154(2):150-4.
Oderda et al 2009
Oderda G, Mura S, Valori A, Brustia R. Idiopathic peptic ulcers in children. J Pediatr Gastroenterol Nutr 2009;48(3):268-70.
Ohkusa et al 2005
Ohkusa T, Maekawa T, Arakawa T, Nakajima M, Fujimoto K, Hoshino E, et al. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis. Aliment Pharmacol Ther 2005;21(11):1331-9.
Orenstein 1991
Orenstein SR. Gastroesophageal reflux. Curr Probl Pediatr 1991;21(5):193-241.
Richter 1997
Richter JE. Extraesophageal presentations of gastroesophageal reflux disease. Semin Gastrointest Dis 1997;8(2):75-89.
Rudolph et al 2001
Rudolph, CD, Mazur LJ, Liptak GS, Baker RD, Boyle JT, Colletti RB, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32 Suppl 2:S1-31.
Ruigómez et al 2011
Ruigómez A, Hungin AP, Lundborg P, Johansson S, Wallander MA, García Rodríguez LA. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2011;23(3):232-7.
Sherman et al 2009
Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, Koletzko S, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009;104(5):1278-95.
Tam et al 2009
Tam YH, Lee KH, To KF, Chan KW, Cheung ST. Helicobacter positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes. J Pediatr Gastroenterol Nutr 2009;48(3):299-305.
Tolia et al 2004
Tolia V, Essenbacher L, Boyer K, Ager J. Gastroesophageal reflux disease (GERD) questionnaire to assess quality of life (QOL) in patients and parents (abs). J Pediatr Gastroenterol Nutr 2004 (Suppl 1);39:P0965.
Tolia and Boyer 2008
Tolia V, Boyer K. Long-term proton pump inhibitor use in children: a retrospective review of safety. Dig Dis Sci 2008;53(2):385-93.
Uemura et al 2008
Uemura N, Inokuchi H, Serizawa H, Chikama T, Yamauchi M, Tsuru T, et al. Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease. J Gastroenterol 2008;43(9):670-8.
Vakil et al 2006
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, the Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101(8):1900-20.
Vandenplas and Sacré-Smits 1987
Vandenplas Y, Sacré-Smits L. Continuous 24-hour esophageal pH monitoring in 285 asymptomatic infants 0-15 months old. J Pediatr Gastroenterol Nutr 1987;6(2):220-4.
Vandenplas et al 1991
Vandenplas Y, Goyvaerts H, Helven R, Sacre L. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991;88(4):834-40.
Vandenplas et al 2009
Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric